Pfizer CEO buys about $1M of shares as institutions add stakes
Eagle Capital Management added 390 Pfizer shares to reach 126,573 shares worth $3.55M, while Delta Financial Advisors increased its stake by 398 shares to 25,266 ($709k) and Pines Wealth Management bought 400 more to 9,430 ($235k). Pfizer CEO Albert Bourla also bought about $1M of stock. Second-quarter results beat expectations, and 2026 revenue guidance was raised to $60.5B–$62.5B.
Coverage (4)
- Pfizer Inc. $PFE Holdings Increased by Willis Investment Counsel (marketbeat.com)
- Pfizer Inc. $PFE Shares Bought by Farther Finance Advisors LLC (marketbeat.com)
- Pfizer Inc. $PFE Shares Acquired by OFI Invest Asset Management (marketbeat.com)
- QRG Capital Management Inc. Acquires 49,804 Shares of Pfizer Inc. $PFE (marketbeat.com)